| Yoram Hahn, MD | |
|
12255 De Paul Dr, Ste 320, Bridgeton, MO 63044-2510 | |
| (314) 344-8100 | |
| (314) 344-8102 |
| Full Name | Yoram Hahn |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 56 Years |
| Location | 12255 De Paul Dr, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275528697 | NPI | - | NPPES |
| 201096229 | Medicaid | MO | |
| 160031462 | Other | MO | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R9961 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hahn Ob Gyn Associates | 8224941604 | 2 |
News Archive
Researchers are moving closer to realizing the clinical potential of drugs that have previously been shown to support healthy aging in animals.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
The U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) today launched an initiative with the Ad Council to encourage clinicians and patients to engage in effective two-way communication to ensure safer care and better health outcomes.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
The SAVI® applicator for breast brachytherapy was used to safely deliver post-lumpectomy radiation therapy to a woman with breast implants, according to a newly published paper in a peer-reviewed journal. The case study showed that SAVI produced an "optimal" clinical outcome and "excellent cosmetic results that pleased the patient," wrote the authors.
› Verified 4 days ago
| Entity Name | Hahn Ob Gyn Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568593978 PECOS PAC ID: 8224941604 Enrollment ID: O20040112000155 |
News Archive
Researchers are moving closer to realizing the clinical potential of drugs that have previously been shown to support healthy aging in animals.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
The U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) today launched an initiative with the Ad Council to encourage clinicians and patients to engage in effective two-way communication to ensure safer care and better health outcomes.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
The SAVI® applicator for breast brachytherapy was used to safely deliver post-lumpectomy radiation therapy to a woman with breast implants, according to a newly published paper in a peer-reviewed journal. The case study showed that SAVI produced an "optimal" clinical outcome and "excellent cosmetic results that pleased the patient," wrote the authors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yoram Hahn, MD 3466 Mckelvey Rd, Bridgeton, MO 63044-2533 Ph: (314) 569-2959 | Yoram Hahn, MD 12255 De Paul Dr, Ste 320, Bridgeton, MO 63044-2510 Ph: (314) 344-8100 |
News Archive
Researchers are moving closer to realizing the clinical potential of drugs that have previously been shown to support healthy aging in animals.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
The U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) today launched an initiative with the Ad Council to encourage clinicians and patients to engage in effective two-way communication to ensure safer care and better health outcomes.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
The SAVI® applicator for breast brachytherapy was used to safely deliver post-lumpectomy radiation therapy to a woman with breast implants, according to a newly published paper in a peer-reviewed journal. The case study showed that SAVI produced an "optimal" clinical outcome and "excellent cosmetic results that pleased the patient," wrote the authors.
› Verified 4 days ago
Sarah Kennedy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3466 Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-344-8100 | |
Dr. Leslie A Scott, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-344-7585 | |
Donna Ann Robey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Bridgeton, MO 63044 Phone: 314-344-8100 Fax: 314-344-8102 | |
Stephanie Lee Cogan-levy, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12277 De Paul Dr, Ste 501s, Bridgeton, MO 63044 Phone: 314-739-8844 Fax: 314-739-5431 | |
Dr. Rochelle Gene Catus, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12255 De Paul Dr, Ste 765, Bridgeton, MO 63044 Phone: 314-298-8646 Fax: 314-291-8646 | |
Dr. Hamnah Tabassum Siddiqui, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-344-7585 |